Description of 3 patients with myasthenia gravis and COVID-19

The COVID-19 pandemic presents two main concerns for patients with myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and some proposed treatments for COVID-19 could cause MG exacerbation.

Source: Journal of the Neurological Sciences - July 21, 2020 Category: Neurology Authors: Netaniel Rein, Nitzan Haham, Efrat Orenbuch-Harroch, Marc Romain, Zohar Argov, Adi Vaknin-Dembinsky, Marc Gotkine Tags: Clinical short communication Source Type: research